Abiopharma

IDEAYA Biosciences to Participate in Upcoming December 2025 Investor Relations Events

Amphastar Pharmaceuticals to Present at the 37th Annual Piper Sandler Healthcare Conference

Scilex Holding Company Announces Exercise of Warrants for $20.3 Million Gross Proceeds

Zymeworks Announces Participation in Upcoming Investor Conferences

Alvotech Announces Approval of AVT03, a Biosimilar to Prolia® and Xgeva® (denosumab) in the European Economic Area

Alvotech Announces Approval of AVT03, a Biosimilar to Prolia® and Xgeva® (denosumab) in the European Economic Area

Markaðsleyfi veitt á Evrópska efnahagssvæðinu fyrir AVT03, hliðstæðu Alvotech við líftæknilyfin Prolia og Xgeva

Riverstone Holdings Limited - Announcement

Exchange Rate Used In Determining Payment Of Interim Dividend

Genenta Reports Long-Term Survival Trends and Immune Findings in Brain Tumor (GBM) Trial